good morning. My name is Daisuke. not interested in us For the treatment of tumors with grenades, Humiles, Althritis, and GHOA, it has been reported that tumor reversion agents are a major problem according to the TSA. RSA is becoming a popular choice by such patients. However, there is an increasing number of well-known options with tumor reversion agents by Altraitis, Humile, Altraitis and GHOA. To resolve these patient choices, we conducted two comparisons. First, for patients with historically increasing well-known options of tumor reversion agents, For patients with GHOA and patients with Altraitis-Humiles-Altraitis-GHOA, Patients with Altraitis-Humiles-Altraitis-GHOA and patients with Altraitis-Humiles-Altraitis-GHOA Next, we compared the clinical radiographic outcomes for this patient. This patient is believed to have reached the age of 80 years or older in the TSA and RS groups. For this patient tendon sample sample sample sample sample sample sample sample sample sample sample sample sample sample sample sample sample sample sample sample sample sample sample・Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample For this patient tendon sample sample sample sample sample sample sample sample sample sample sample sample sample sample sample sample sample sample sample sample sample sample sample・Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Sample Using historical analysis Using electro-microscopic analysis Using historical analysis Using electro-microscopic analysis For patients with CTA and OA For patients with CTA and OA For patients with CTA and OA, the historical analysis and appearance are similar for patients in the OA and CTA groups. For patients with CTA and OA, bonus scores ranged from 0 to 6, about 2.7 points. However, case 3 has a bonus score of 6. Cases 1 and 2 are well-analyzed collation cells about analysis about analysis about analysis about analysis about analysis about analysis about analysis Analysis about analysis about analysis about analysis about analysis about analysis about analysis about analysis about analysis about analysis about analysis about analysis About analysis about analysis about analysis about analysis about analysis about analysis about analysis about analysis about analysis about analysis about analysis About analysis about analysis about analysis about analysis about analysis about analysis about analysis about analysis about analysis about analysis about analysis about analysis The RSA group outperformed the TSA group by Kansan score and ROM RSA and RS group bonus scores were higher than those of control patients K3 group was higher than the Edgrenade group Young etol showed 55% of cuff dysfunction According to the results and conclusions, pediatric patients without cuff dysfunction Poor medical outcomes for patients after TSA group Thank you for your attention

tumor reversion agents

clinical radiographic outcomes

RSA

historical analysis

pediatric patients